Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR Medicine, Hematology and Medical Oncology
Biography
I recently joined Mount Sinai as an Assistant Professor in The Tisch Cancer Insitute and the Division of Hematology and Medical Oncology and see patients at the Dubin Breast Center, providing clinical medical oncology services to patients with breast cancer. Prior to my appointment at Mount Sinai, I was in practice at Memorial Sloan-Kettering's regional care facility in Commack, Long Island. I received my MD from Albert Einstein College of Medicine and was an intern and resident in Internal Medicine at Montefiore Medical Center and a fellow in Hematology/Oncology at the NYU School of Medicine.
Fingerprint
Dive into the research topics where Julie Fasano is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Monitoring of estradiol levels in premenopausal women receiving adjuvant abemaciclib and ovarian function suppression
Kessler, A. J., Patel, R., Gallagher, E. J., Sheng, T., Mendu, D. R., Tiersten, A., Klein, P., Bhardwaj, A. S., Goel, A., Sparano, J. A., Shao, T. & Fasano, J., Oct 2024, In: Breast Cancer Research and Treatment. 207, 3, p. 529-532 4 p.Research output: Contribution to journal › Article › peer-review
-
Results of a Phase Ib Study Investigating Durvalumab in Combination with Eribulin in Patients with HER2-Negative Metastatic Breast Cancer and Recurrent Ovarian Cancer
Landry, C. A., Blanter, J., Ru, M., Fasano, J., Klein, P., Shao, T., Bhardwaj, A. & Tiersten, A., 1 Jan 2024, In: Oncology. 102, 1, p. 9-16 8 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Discrepancies in estradiol levels in a premenopausal woman receiving abemaciclib despite ovarian function suppression and bilateral salpingo-oophorectomy
Kessler, A. J., Patel, R., Gallagher, E. J., Shao, T. & Fasano, J., Mar 2023, In: Current Problems in Cancer: Case Reports. 9, 100224.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Optimism and coping: do they influence health outcomes in women with breast cancer? A systemic review and meta-analysis
Fasano, J., Shao, T., Huang, H. H., Kessler, A. J., Kolodka, O. P. & Shapiro, C. L., 1 Oct 2020, In: Breast Cancer Research and Treatment. 183, 3, p. 495-501 7 p.Research output: Contribution to journal › Review article › peer-review
44 Scopus citations -
Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
Dang, C., Iyengar, N., Datko, F., D'Andrea, G., Theodoulou, M., Dickler, M., Goldfarb, S., Lake, D., Fasano, J., Fornier, M., Gilewski, T., Modi, S., Gajria, D., Moynahan, M. E., Hamilton, N., Patil, S., Jochelson, M., Norton, L., Baselga, J. & Hudis, C., 10 Feb 2015, In: Journal of Clinical Oncology. 33, 5, p. 442-447 6 p.Research output: Contribution to journal › Article › peer-review
Open Access71 Scopus citations
Press/Media
-
New Findings in Kinase Inhibitors Described from Icahn School of Medicine at Mount Sinai (Monitoring of Estradiol Levels In Premenopausal Women Receiving Adjuvant Abemaciclib and Ovarian Function Suppression)
Goel, A., Sparano, J., Klein, P., Bhardwaj, A., Tiersten, A., Gallagher, E. & Fasano, J.
2/09/24
1 item of Media coverage
Press/Media
-
Tisch Cancer Institute Researcher Has Provided New Study Findings on Breast Cancer (Abstract PO5-02-01: Concerning Discrepancies in Estradiol Levels in Premenopausal Women Receiving Abemaciclib and Ovarian Function Suppression)
Goel, A., Klein, P., Bhardwaj, A., Tiersten, A., Gallagher, E., Fasano, J. & Sparano, J.
22/05/24
1 item of Media coverage
Press/Media
-
Tisch Cancer Institute Researcher Describes Recent Advances in Breast Cancer (Abstract PO2-06-07: A Randomized Phase II Comparison of Single-Agent Carboplatin versus the Combination of Carboplatin and Everolimus for the Treatment of Advanced ...)
Moshier, E., Goel, A., Klein, P., Bhardwaj, A., Tiersten, A., Fasano, J. & Sparano, J.
20/05/24
1 item of Media coverage
Press/Media